Deep Learning Model Predicts Response to Combination Therapy

Deep Learning Model Predicts Response to Combination Therapy Prior to Treatment in HCC

Researchers developed a web server that can help predict therapeutic responses to combination lenvatinib and immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma (HCC).

Related Keywords

, Structural Biotechnology , Liver Cancer , Hcc ,